<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362304">
  <stage>Registered</stage>
  <submitdate>10/04/2012</submitdate>
  <approvaldate>18/04/2012</approvaldate>
  <actrnumber>ACTRN12612000439842</actrnumber>
  <trial_identification>
    <studytitle>An Observational Study of Basilar Apex Brain Aneurysms Treated With WEB Aneurysm Embolization System</studytitle>
    <scientifictitle>An observational study to assess the progress of basilar apex aneurysms after treatment with the WEB Aneurysm Embolization System</scientifictitle>
    <utrn />
    <trialacronym>WEBCAST-B</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Intracranial wide-neck basilar apex aneurysms</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Hypertension</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>An observational post-market, open label, multicenter study designed to assess the clinical utility of the WEB Aneurysm Embolization System in the treatment of basilar apex aneurysms.  The study is longitudinal and will follow study participants for at least a year after treatment.</interventions>
    <comparator>nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Stasis and chronic occlusion of aneurysm after treatment with WEB Aneurysm Embolization System.  Outcome will be evaluated by an independent core lab using a three-point classification system in addition to other occlusion assessment methods.</outcome>
      <timepoint>6-month post procedure and for at least 12 months after the initial embolization procedure.  All follow-ups will be conducted per institutional standard of care.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- Saccular basilar apex (BA) aneuryms
- Diameter and width of the aneurysm is appropriate size for treatment with the WEB Aneurysm
- Embolization System per device Instructions for Use
- Aneurysm neck size &gt;= 4mm
- Dome-to-Neck (DN) ratio &gt;= 1.0
- Sign and date EC-approved written informed consent prior to initiation of study</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>- Must not have clinical or angiographic evidence of vasospasm
- Must not have lesion with characteristics unsuitable for endovascular treatment
- Must not have neurologic or psychiatric conditions, which preclude ability to comply with al aspects of the screening, evaluation, treatment, and the post-procedure fol ow-up schedule Must not be concurrently involved in another investigational or post-market study
- Must not have received any investigational device for treatment of the target intracranial aneurysm prior to entry into this trial</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/12/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Budapest</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Sequent Medical, Inc.</primarysponsorname>
    <primarysponsoraddress>11A Columbia
Aliso Viejo, CA 92656</primarysponsoraddress>
    <primarysponsorcountry>United States of America</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Sequent Medical, Inc.</fundingname>
      <fundingaddress>11A Columbia
Aliso Viejo, CA 92656</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>An observational post-market, open label, multicenter study designed to assess the clinical utility of the WEB Aneurysm Embolization System.  The proposed clinical study is a non-randomized, multi-center, prospective confirmatory study to assess the safety and efficacy of the WEB Aneurysm Embolization System.</summary>
    <trialwebsite>nil</trialwebsite>
    <publication>Klisch, J., Sychra., Vojtech, S., Strasilla, C., Liebig, T., &amp; Fiorella, D. (2011). The Woven endobridge cerebral aneurysm embolization Device (WEB II): Initial clinical experience. Neuroradiol, 53, 599-607. 

Ding, Y. H., Lewis, D. A., Kadirvel, R., Dai, D., &amp; Kallmes, D. F. (2011). The Woven endobridge: A New aneurysm occlusion device. AJNR, 32.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Medical Research Council Scientific and Research Ethics Committee</ethicname>
      <ethicaddress>Budapest H-1051 Arany Jnos u. 6-8.</ethicaddress>
      <ethicapprovaldate>25/10/2011</ethicapprovaldate>
      <hrec>745/PI/11</hrec>
      <ethicsubmitdate />
      <ethiccountry>Hungary</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Amy Walters</name>
      <address>11A Columbia
Aliso Viejo, CA 92565</address>
      <phone>+1 949-830-9600 X 121</phone>
      <fax />
      <email>amyw@sequentmedical.com</email>
      <country>United States of America</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Kathy Akagha, MPH</name>
      <address>11A Columbia
Aliso Viejo, CA 92565</address>
      <phone>+1 949-830-9600 X 127</phone>
      <fax />
      <email>kathya@sequentmedical.com</email>
      <country>United States of America</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Kathy Akagha, MPH</name>
      <address>11A Columbia
Aliso Viejo, CA 92565</address>
      <phone>949-830-9600 X 127</phone>
      <fax />
      <email>kathya@sequentmedical.com</email>
      <country>United States of America</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>